Your browser doesn't support javascript.
loading
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis.
Koudriavtseva, Tatiana; Lorenzano, Svetlana; Cellerino, Maria; Truglio, Mauro; Fiorelli, Marco; Lapucci, Caterina; D'Agosto, Giovanna; Conti, Laura; Stefanile, Annunziata; Zannino, Silvana; Filippi, Maria Maddalena; Cortese, Antonio; Piantadosi, Carlo; Maschio, Marta; Maialetti, Andrea; Galiè, Edvina; Salvetti, Marco; Inglese, Matilde.
Affiliation
  • Koudriavtseva T; Medical Direction, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Rome, Italy.
  • Lorenzano S; Department of Clinical Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO), Rome, Italy.
  • Cellerino M; Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
  • Truglio M; Department of Clinical Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO), Rome, Italy.
  • Fiorelli M; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
  • Lapucci C; Clinical Pathology and Cancer Biobank, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Rome, Italy.
  • D'Agosto G; Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
  • Conti L; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
  • Stefanile A; Clinical Pathology and Microbiology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Gallicano Dermatological Institute, Rome, Italy.
  • Zannino S; Clinical Pathology and Cancer Biobank, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Rome, Italy.
  • Filippi MM; Clinical Pathology and Cancer Biobank, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Rome, Italy.
  • Cortese A; Department of Clinical Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO), Rome, Italy.
  • Piantadosi C; Neuroscience and Imaging, Fatebenefratelli Hospital, Rome, Italy.
  • Maschio M; Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
  • Maialetti A; Unità Operativa Complessa (UOC) Neurology, San Giovanni-Addolorata Hospital, Rome, Italy.
  • Galiè E; Department of Clinical Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO), Rome, Italy.
  • Salvetti M; Department of Clinical Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO), Rome, Italy.
  • Inglese M; Department of Clinical Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO), Rome, Italy.
Front Immunol ; 14: 1226616, 2023.
Article in En | MEDLINE | ID: mdl-37583699
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Adult / Humans / Middle aged Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Adult / Humans / Middle aged Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Country of publication: